» Articles » PMID: 18272544

Activated Neutrophils Induce an HMSH2-dependent G2/M Checkpoint Arrest and Replication Errors at a (CA)13-repeat in Colon Epithelial Cells

Overview
Journal Gut
Specialty Gastroenterology
Date 2008 Feb 15
PMID 18272544
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Chronic inflammation in ulcerative colitis is associated with increased risk for colorectal cancer. Its molecular pathway of cancer development is poorly understood. We investigated the role of neutrophil-derived cellular stress in an in vitro model of neutrophils as effectors and colon epithelial cells as targets, and tested for changes in cell cycle distribution and the appearance of replication errors.

Design: Colon epithelial cells with different mismatch repair phenotypes were co-cultured with activated neutrophils. Target cells were analysed for cell cycle distribution and replication errors by flow cytometry. Changes in nuclear and DNA-bound levels of mismatch repair- and checkpoint-related proteins were analysed by western blotting.

Results: Activated neutrophils cause an accumulation of target cells in G2/M, consistent with the installation of a DNA-damage checkpoint. Cells that do not express hMSH2, p53 or p21(waf1/cip1) failed to undergo the G2/M arrest. Phosphorylation of p53 at site Ser15 and Chk1 at Ser317, as well as accumulation of p21(waf1/cip1), was observed within 8-24 h. Superoxide dismutase and catalase were unable to overcome this G2/M arrest, possibly indicating that neutrophil products other than superoxide or H(2)O(2) are involved in this cellular response. Finally, exposure to activated neutrophils increased the number of replication errors.

Conclusions: By using an in vitro co-culture model that mimics intestinal inflammation in ulcerative colitis, we provide molecular evidence for an hMSH2-dependent G2/M checkpoint arrest and for the presence of replication errors.

Citing Articles

The Association Between Neutrophil-Percentage-to-Albumin Ratio (NPAR) and Mortality Among Individuals With Cancer: Insights From National Health and Nutrition Examination Survey.

Li X, Wu M, Chen M, Liu R, Tao Q, Hu Y Cancer Med. 2025; 14(2):e70527.

PMID: 39831739 PMC: 11744675. DOI: 10.1002/cam4.70527.


The Dark Knight: Functional Reprogramming of Neutrophils in the Pathogenesis of Colitis-Associated Cancer.

Ghosh S, Zanoni I Cancer Immunol Res. 2024; 12(10):1311-1319.

PMID: 39270036 PMC: 11444878. DOI: 10.1158/2326-6066.CIR-23-0642.


Myeloid-derived suppressor cells in cancer and cancer therapy.

Lasser S, Ozbay Kurt F, Arkhypov I, Utikal J, Umansky V Nat Rev Clin Oncol. 2024; 21(2):147-164.

PMID: 38191922 DOI: 10.1038/s41571-023-00846-y.


Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach.

Fernandes R, Costa C, Fernandes R, Barros A Biomedicines. 2023; 11(12).

PMID: 38137361 PMC: 10740737. DOI: 10.3390/biomedicines11123140.


E2Fs co-participate in cadmium stress response through activation of MSHs during the cell cycle.

Zheng W, Li W, Peng Y, Shao Y, Tang L, Liu C Front Plant Sci. 2022; 13:1068769.

PMID: 36531377 PMC: 9749859. DOI: 10.3389/fpls.2022.1068769.


References
1.
Johnson R, Kovvali G, Guzder S, Amin N, Holm C, Habraken Y . Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair. J Biol Chem. 1996; 271(45):27987-90. DOI: 10.1074/jbc.271.45.27987. View

2.
Jacob S, Aguado M, Fallik D, Praz F . The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 2001; 61(17):6555-62. View

3.
Simelyte E, Boyle D, Firestein G . DNA mismatch repair enzyme expression in synovial tissue. Ann Rheum Dis. 2004; 63(12):1695-9. PMC: 1754862. DOI: 10.1136/ard.2003.017210. View

4.
Brestel E . Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence. Biochem Biophys Res Commun. 1985; 126(1):482-8. DOI: 10.1016/0006-291x(85)90631-x. View

5.
Chen P, Gatei M, Oconnell M, Khanna K, Bugg S, Hogg A . Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells. Oncogene. 1999; 18(1):249-56. DOI: 10.1038/sj.onc.1202257. View